QS Pharma

Boothwyn, United States Founded: 2002 • Age: 24 yrs Acquired By Quotient Sciences
Contract development and manufacturing for small molecule pharmaceuticals are offered.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About QS Pharma

QS Pharma is a company based in Boothwyn (United States) founded in 2002 was acquired by Quotient Sciences in February 2017. QS Pharma operates in a competitive market with competitors including Almac Group, Seqens, Asymchem, Aurobindo Pharma and Indoco Remedies, among others.

  • Headquarter Boothwyn, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Quotient Sciences

    (Feb 14, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of QS Pharma

Premium access

Detailed funding history for QS Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in QS Pharma

QS Pharma has secured backing from 1 investor. Prominent investors backing the company include Quotient Sciences.

All
Investor Description Founded Year Domain Location
APIs and finished dosage forms are developed and manufactured.
Locked Locked Locked
Premium access

Investor details for QS Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by QS Pharma

Investments
Premium access

Investment portfolio details for QS Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - QS Pharma

Premium access

Detailed financials for QS Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Qs Pharma Comparisons

QS Pharma Primary company
Description
Contract development and manufacturing for small molecule ph...
Location
Boothwyn, United States
Founded Year
2002
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for QS Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of QS Pharma

QS Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Seqens, Asymchem, Aurobindo Pharma and Indoco Remedies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
Contract manufacturing services for small molecules and peptides are provided.
Locked Locked Locked
APIs and peptides are developed and manufactured by Asymchem.
Locked Locked Locked
Generic biocatalytic solutions are provided for pharmaceutical applications.
Locked Locked Locked
APIs manufacturing and formulation services are provided in therapeutic segments.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Premium access

Detailed competitors of QS Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Qs Pharma

Premium access

Complete news archive for QS Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about QS Pharma

QS Pharma was founded in 2002.

QS Pharma is headquartered in Boothwyn, United States. It is registered at Boothwyn, Pennsylvania, United States.

QS Pharma, founded in 2002 and based in Boothwyn, United States, operates as a contract development and manufacturing organization in the biopharmaceutical sector. Services encompass early-stage screening and identification of new chemical entities, preclinical toxicology formulations, and development of dosage forms for clinical trials, extending to commercial manufacturing of approved drug candidates.

QS Pharma's top competitors include Concord Biotech, Almac Group and Indoco Remedies.

QS Pharma has 1 investor. Key investors include Quotient Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available